Status:

UNKNOWN

Pilot Study Among Type 2 Diabetes Patients Investigating the Effects of Computerized Cognitive and Physical Activity Programs Combined or Single (DIASCOP)

Lead Sponsor:

University Hospital, Clermont-Ferrand

Collaborating Sponsors:

University of Clermont Auvergne (UCA) / LAPSCO

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

50-70 years

Phase:

NA

Brief Summary

The purpose of this study is to assess the cognitive benefits of combined physical activity and cognitive training on cognitive health compare to physical activity or cognitive training programs singl...

Detailed Description

The growing Type 2 diabetes prevalence is associated with health, economic and social consequences. As such, type 2 diabetes is recognized as major health issue. Health care should go on after being d...

Eligibility Criteria

Inclusion

  • Male or female aged between 50 and 70 years old, suffering from type 2 diabetes.
  • Normal or corrected sight and audition. Being able to engage in physical activity. Being able to give enlightened consent. Being affiliate to social welfare

Exclusion

  • Being unable to meet the study conditions or to answer in French to surveys. Any condition considered, by the investigator, as incompatible with the participation in the study.
  • Major incapacities. Refusal of participation.

Key Trial Info

Start Date :

June 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT04915339

Start Date

June 1 2021

End Date

June 1 2023

Last Update

June 7 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Clermont-Ferrand

Clermont-Ferrand, France, 63000